Hospital pathogens are microorganisms that patients can get infected with in connection with hospital treatment.
Synonyms
Hospital germs
Detailed description
The most common hospital pathogens are enterococci, Pseudomonas aeruginosa and staphylococci. Inadequate hygiene measures and incorrectly applied antibiotics are two reasons for their spread. The increase of hospital pathogens carrying antibiotic resistances is particularly alarming. Hospital-acquired infections can lead to wound infections and sepsis as well as infections of the airways and the urinary tract.
An international team of researchers, with the participation of Giessen University and the German Center for Infection Research (DZIF), discovered a new active substance effective against gram
The Helmholtz Centre for Infection Research and Evotec AG are joining forces in the development of new broadband antibiotics targeting Gram-negative pathogens. The research activities will initially
The clinical research unit led by Prof. Evelina Tacconelli combines the information from clinical, microbiological and basic research. Scientists and physicians are working closely together to tackle the problem of increasing antibiotic-resistant germs in hospitals. Samples are collected in clinical ...
United against Infections Infectious diseases, such as AIDS, bacterial respiratory diseases or tuberculosis, are among the leading causes of death worldwide. They are triggered by a variety of
In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents ...
Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in
DZIF researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) produced a molecule that provides a way to visualise Pseudomonas infection. The scientists published their
In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded
